Private Advisor Group LLC Has $359,000 Stock Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Private Advisor Group LLC lessened its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 6.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 2,698 shares of the company’s stock after selling 172 shares during the quarter. Private Advisor Group LLC’s holdings in Addus HomeCare were worth $359,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. Texas Permanent School Fund Corp raised its position in Addus HomeCare by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock worth $1,636,000 after purchasing an additional 82 shares in the last quarter. Arizona State Retirement System increased its holdings in shares of Addus HomeCare by 2.0% during the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after buying an additional 87 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares in the last quarter. Inspire Investing LLC increased its holdings in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares in the last quarter. Finally, Azzad Asset Management Inc. ADV increased its holdings in shares of Addus HomeCare by 1.3% during the second quarter. Azzad Asset Management Inc. ADV now owns 8,436 shares of the company’s stock worth $980,000 after buying an additional 110 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling

In related news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now directly owns 3,866 shares in the company, valued at $502,695.98. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares in the company, valued at $502,695.98. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 over the last ninety days. Company insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several research analyst reports. Macquarie reissued an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday. KeyCorp initiated coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. Stephens reissued an “overweight” rating and set a $138.00 price target on shares of Addus HomeCare in a research note on Tuesday, August 6th. Royal Bank of Canada reissued an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Finally, TD Cowen raised their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $131.38.

Addus HomeCare Stock Down 3.7 %

Shares of NASDAQ ADUS opened at $124.17 on Wednesday. The company’s fifty day moving average is $129.93 and its 200-day moving average is $120.66. The stock has a market cap of $2.25 billion, a price-to-earnings ratio of 28.13, a P/E/G ratio of 2.29 and a beta of 1.04. Addus HomeCare Co. has a twelve month low of $81.51 and a twelve month high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the firm posted $1.03 earnings per share. On average, research analysts anticipate that Addus HomeCare Co. will post 4.57 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.